Home About us Contact
|
Home About us Contact | ||
|
|
||
Working Party (work + party)
Selected AbstractsPM 8/2(1): ConiferaeEPPO BULLETIN, Issue 3 2009Article first published online: 27 NOV 200 Specific scope The purpose of the EPPO Standard on Coniferae is to recommend to EPPO Member Governments the phytosanitary measures, which they should use or require for Coniferae plants and plant products moving in international trade, to prevent the introduction and spread of regulated pests. Certain of these recommendations are addressed to all EPPO Member Governments, others are addressed only to countries considered to face a certain level of risk from the introduction and spread of the pests recommended for regulation concerned. These recommendations are derived: ,,from the EPPO Standards PM 1/2 (EPPO A1 and A2 lists) ,,from the former EPPO standard PM 2 (pest-specific phytosanitary measures) (which was withdrawn in 2006 by the Working Party on Phytosanitary Regulations) ,,from Pest Risk Analysis ,,from the Working Party on Phytosanitary Regulations ,,from the ISPM n°15 ,Guidelines for regulating wood packaging material in international trade'. Specific approval and amendment Approved in 2009-09. [source] Protocols for the diagnosis of quarantine pests,EPPO BULLETIN, Issue 3-4 2000EPPO member countries have recognized the need for a harmonized approach to detection and identification methods for quarantine pests. In 1998, EPPO started anew project to prepare diagnostic protocols for the quarantine pests of the EPPO region. The work is conducted by the Panel on Diagnostics, which is under the authority of the Working Party on Phytosanitary Regulations. The Panel consists of 10 experts in different fields. When necessary, expert groups on specific disciplines are called upon. The Panel agreed on a suitable common format for the protocols and a procedure for producing the best quality of diagnostic protocols. As there are about 325 quarantine pests for the region (listed in the EPPO A1 and A2 lists of quarantine pests and in the Annexes of EU Directive 77/93), it was necessary to decide upon a priority list of the organisms for which protocols should be developed first. At the moment, 52 protocols are at different stages of preparation. [source] Practical guidelines for treating inflammatory bowel disease safely with anti-tumour necrosis factor therapy in AustraliaINTERNAL MEDICINE JOURNAL, Issue 2 2010W. Connell Abstract Anti-tumour necrosis factor (TNF) therapy is an effective but expensive option for treating inflammatory bowel disease (IBD). Its use is generally reserved for patients with severe refractory disease, often involving long-term administration. Anti-TNF therapy has the potential to be associated with various adverse effects, such as infection, malignancy and immunogenicity. Clinicians and patients should be familiar with these possibilities and adopt appropriate precautions prior to and during treatment to minimize risk. Guidelines have been developed for Australian prescribers intending to use anti-TNF therapy in IBD by a Working Party commissioned by IBD-Australia, a Special Interest Group affiliated with the Gastroenterology Society of Australia. [source] International Society of Blood Transfusion Working Party on EducationISBT SCIENCE SERIES: THE INTERNATIONAL JOURNAL OF INTRACELLULAR TRANSPORT, Issue 1 2008F. Moftah [source] Minimal hepatic encephalopathy: Consensus statement of a working party of the Indian National Association for Study of the LiverJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Issue 6 2010Radha K Dhiman Abstract Hepatic encephalopathy (HE) is a major complication that develops in some form and at some stage in a majority of patients with liver cirrhosis. Overt HE occurs in approximately 30,45% of cirrhotic patients. Minimal HE (MHE), the mildest form of HE, is characterized by subtle motor and cognitive deficits and impairs health-related quality of life. The Indian National Association for Study of the Liver (INASL) set up a Working Party on MHE in 2008 with a mandate to develop consensus guidelines on various aspects of MHE relevant to clinical practice. Questions related to the definition of MHE, its prevalence, diagnosis, clinical characteristics, pathogenesis, natural history and treatment were addressed by the members of the Working Party. [source] Clinical and prognostic features of plasmacytomas: A multicenter study of Turkish Oncology Group-Sarcoma Working PartyAMERICAN JOURNAL OF HEMATOLOGY, Issue 9 2008Sevil Kilciksiz To identify the outcomes of prognostic factors of solitary plasmacytoma mainly treated with local radiotherapy (RT). The data were collected from 80 patients with solitary plasmacytoma (SP). Forty patients (50.0%) received radiotherapy (RT) alone while 38 of them (47.5%) were treated with surgery (S) and RT. The median radiation dose was 46 Gy (range 30,64). The median follow up was 2.41 years (range 0.33,12.33). Ten-year overall survival (OS) and local relapse-free survival (LRFS) were 73% and 94%, respectively. The median progression-free survival (PFS) and multiple myeloma-free survival (MMFS) were 3.5 years and 4.8 years, respectively. On multivariate analyses, the favorable factors were radiotherapy dose of ,50 Gy and RT + S for PFS and younger age for MMFS. For the patients with medullary plasmacytoma, the favorable factor was younger age for MMFS. RT at ,50 Gy and RT + S may be favorable prognostic factors on PFS. Younger patients, especially with head-neck lesion and without pre-RT macroscopic tumor, seem to have the best outcome when treated with RT ± S. Progression to MM remains as the main problem especially for older patients. Am. J. Hematol., 2008. © 2008 Wiley-Liss, Inc. [source] | ||||||||||